0001104659-20-010065.txt : 20200203
0001104659-20-010065.hdr.sgml : 20200203
20200203215053
ACCESSION NUMBER: 0001104659-20-010065
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200131
FILED AS OF DATE: 20200203
DATE AS OF CHANGE: 20200203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coughlin Christina M.
CENTRAL INDEX KEY: 0001799032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38586
FILM NUMBER: 20570543
MAIL ADDRESS:
STREET 1: C/O RUBIUS THERAPEUTICS, INC.
STREET 2: 399 BINNEY ST., SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rubius Therapeutics, Inc.
CENTRAL INDEX KEY: 0001709401
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042688109
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-679-9600
MAIL ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
a4.xml
4
X0306
4
2020-01-31
0
0001709401
Rubius Therapeutics, Inc.
RUBY
0001799032
Coughlin Christina M.
C/O RUBIUS THERAPEUTICS, INC.
399 BINNEY STREET, SUITE 300
CAMBRIDGE
MA
02139
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
7.80
2020-01-31
4
A
0
375000
0
A
2030-01-30
Common Stock
375000
375000
D
25% of this option shall vest on January 6, 2021, then in 12 equal quarterly installments thereafter.
/s/ Joanne M. Protano, Attorney-in-Fact
2020-02-03